Markets |
Wall St. loses ground on growth fears, oil
slide
DJ: 17,750.91 -140.25 NAS: 4,763.22
-54.37 S&P: 2,063.37
-18.06
(Reuters) U.S.
stocks fell on Tuesday after weak economic data in China and Europe reignited
worries about global growth, while oil prices dropped for a second day,
dragging down energy shares. Bucking the day's trend, Apple (AAPL.O) rose 1.6 percent to $95.18, breaking
an eight-session streak of losses.
Activity in China's
factories shrank for the 14th straight month in April as demand
stagnated, a private survey showed. Britain's manufacturing output also unexpectedly shrank last
month to its lowest level in three years.
U.S. oil
prices CLc1 settled down
2.5 percent as rising output from the Middle East renewed concerns about
global oversupply. The S&P energy index .SPNY, down 2.2 percent, led
declines in the benchmark index.
Still, the recent recovery in oil prices, along with a softer
dollar, have helped the
S&P 500 rebound from a steep selloff earlier this year. The
benchmark index is now up
about 1 percent for the year so far.
"We had a nice rally yesterday, and in essence we're
peeling that back today. The market is stuck in a trading range that is at the
intersection of full valuations in U.S. equities and news that has not been
necessarily overwhelming positive," said Mark Luschini, chief investment
strategist at Janney Montgomery Scott in Philadelphia.
Shares of U.S. automakers were mostly lower as
stronger-than-expected sales for April were not enough to offset worries that
the industry's recovery is running out of steam. Shares of Ford (F.N) fell
1.4 percent to $13.43.
The Dow Jones industrial
average .DJI closed down 140.25 points, or 0.78
percent, to 17,750.91, the S&P 500 .SPX lost 18.06 points, or 0.87 percent, to
2,063.37 and the Nasdaq Composite .IXIC dropped 54.37 points, or 1.13 percent,
to 4,763.22.
The biggest economic release on the agenda this week is monthly U.S. payrolls, due on Friday.
Last week, U.S. data showed tepid growth in first-quarter gross domestic
product and a softening in the Fed's preferred measure of inflation.
Besides Apple, some healthcare companies were a bright spot,
with Pfizer (PFE.N) up
2.7 percent at $33.70 after reporting a rise in quarterly revenue and raising
its forecasts for the year.
Shares of drugmaker Mallinckrodt Plc (MNK.N) were
up 6.8 percent at $64.84 following its results, while Mylan (MYL.O) was
up 2.3 percent at $43.69, also after results.
About 7.8
billion shares changed hands on U.S. exchanges, compared with the 7.1
billion daily average for the past 20 trading days, according to Thomson
Reuters data.
Declining issues outnumbered advancing ones on the NYSE by 2,286
to 741, for a 3.09-to-1 ratio on the downside; on the Nasdaq, 2,083 issues fell
and 738 advanced for a 2.82-to-1 ratio favoring decliners.
The S&P 500 posted 13 new 52-week highs and 3 new lows; the
Nasdaq recorded 30 new highs and 47 new lows.
No comments:
Post a Comment